Does TUCATINIB Cause Palmar-plantar erythrodysaesthesia syndrome? 355 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 355 reports of Palmar-plantar erythrodysaesthesia syndrome have been filed in association with TUCATINIB (TUKYSA). This represents 5.9% of all adverse event reports for TUCATINIB.
355
Reports of Palmar-plantar erythrodysaesthesia syndrome with TUCATINIB
5.9%
of all TUCATINIB reports
16
Deaths
49
Hospitalizations
How Dangerous Is Palmar-plantar erythrodysaesthesia syndrome From TUCATINIB?
Of the 355 reports, 16 (4.5%) resulted in death, 49 (13.8%) required hospitalization.
Is Palmar-plantar erythrodysaesthesia syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 355 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Malignant neoplasm progression (361)
Product dose omission issue (332)
Asthenia (322)
Decreased appetite (286)
What Other Drugs Cause Palmar-plantar erythrodysaesthesia syndrome?
CAPECITABINE (5,294)
CABOZANTINIB S-MALATE (2,706)
REGORAFENIB (1,230)
LENVATINIB (1,211)
BEVACIZUMAB (1,079)
SORAFENIB (1,040)
OXALIPLATIN (980)
SUNITINIB MALATE (929)
TRASTUZUMAB (919)
FLUOROURACIL (837)
Which TUCATINIB Alternatives Have Lower Palmar-plantar erythrodysaesthesia syndrome Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI